Showing 51 - 60 of 137
Persistent link: https://www.econbiz.de/10012665582
Persistent link: https://www.econbiz.de/10012221975
Persistent link: https://www.econbiz.de/10012004857
Persistent link: https://www.econbiz.de/10012490409
The objective of this paper is to examine how well the QALY captures the health gains generated by cancer treatments, with particular focus on the methods for constructing QALYs preferred by the UK National Institute for Health and Clinical Excellence (NICE). Data were obtained using a keyword...
Persistent link: https://www.econbiz.de/10010614310
Persistent link: https://www.econbiz.de/10010666521
Persistent link: https://www.econbiz.de/10014327976
Background It is widely assumed that the principal objective of healthcare is to maximise health. However, people may be willing to sacrifice aggregate health gain in order to direct resources towards those who are worst off in terms of the severity of their pre-treatment health state.Objectives...
Persistent link: https://www.econbiz.de/10008483570
The numbers of quality-adjusted life years (QALYs) gained are increasingly being used to represent the gains in individual utility from treatment. This requires that the value of a health improvement to an individual is a simple product of gains in quality of life and length of life. The article...
Persistent link: https://www.econbiz.de/10009440160
The way Time Trade Off (TTO) values are elicited for states of health considered ‘worse than being dead’ has important implications for the mean values used in economic evaluation. Conventional approaches to TTO, as used in the UK’s ‘MVH’ value set, are problematic because they require...
Persistent link: https://www.econbiz.de/10011268947